Analysis of hematological indexes of COVID-19 patients from fever clinics in Suzhou, China
Jindan Kong
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Department of Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorTing Wang
Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorZou Di
Department of Critical Care Medicine, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, China
Search for more papers by this authorBingyu Shi
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Search for more papers by this authorXiaoming Yu
Department of Critical Care Medicine, The Sixth People's Hospital of Kunshan, Kunshan, China
Search for more papers by this authorChaofa Huang
Department of Critical Care Medicine, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Search for more papers by this authorYan Yang
Department of Critical Care Medicine, The First People's Hospital of Kunshan, Kunshan, China
Search for more papers by this authorHaiwei Sun
Department of Emergency and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorDejing Yuan
Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorCorresponding Author
Depei Wu
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Correspondence
Depei Wu and Jianhong Fu, Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Shizi Street 188, Suzhou 215006, China.
Emails: [email protected] (DW); [email protected] (JF)
Search for more papers by this authorCorresponding Author
Jianhong Fu
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Correspondence
Depei Wu and Jianhong Fu, Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Shizi Street 188, Suzhou 215006, China.
Emails: [email protected] (DW); [email protected] (JF)
Search for more papers by this authorJindan Kong
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Department of Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorTing Wang
Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorZou Di
Department of Critical Care Medicine, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, China
Search for more papers by this authorBingyu Shi
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Search for more papers by this authorXiaoming Yu
Department of Critical Care Medicine, The Sixth People's Hospital of Kunshan, Kunshan, China
Search for more papers by this authorChaofa Huang
Department of Critical Care Medicine, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Search for more papers by this authorYan Yang
Department of Critical Care Medicine, The First People's Hospital of Kunshan, Kunshan, China
Search for more papers by this authorHaiwei Sun
Department of Emergency and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorDejing Yuan
Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China
Search for more papers by this authorCorresponding Author
Depei Wu
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Correspondence
Depei Wu and Jianhong Fu, Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Shizi Street 188, Suzhou 215006, China.
Emails: [email protected] (DW); [email protected] (JF)
Search for more papers by this authorCorresponding Author
Jianhong Fu
Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
Correspondence
Depei Wu and Jianhong Fu, Department of Hematology, The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Shizi Street 188, Suzhou 215006, China.
Emails: [email protected] (DW); [email protected] (JF)
Search for more papers by this authorJindan Kong, Ting Wang and Di Zou contributed equally to this work.
REFERENCES
- 1Fan BE, Chong V, Chan S, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020; 95(6): E131-E134.
- 2Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844-847.
- 3Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.
- 4Yao XH, Li TY, He ZC, et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020; 49: E9.
- 5Russell CD, Parajuli A, Gale HJ, et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: a systematic review and meta-analysis. J Infect. 2019; 78(5): 339-348.
- 6Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020. ciaa248. [Epub ahead of print].
- 7Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. e200994. [Epub ahead of print].
- 8Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious diseases society of america guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020. ciaa478. [Epub ahead of print].
- 9Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020; 395(10229): 1054-1062.
Citing Literature
